Cancer researchers claim to have found a ‘molecular switch’ that can render anti-cancer drugs less effective in pancreatic cancer.  Pancreatic cancer is one of the most deadly forms of cancer, and is the fourth leading cause of cancer death in the United States.  This is largely due to the fact that only 10% of pancreatic cancers remain in the pancreas.  They usually metastasize.

Researchers readily admit that the tumors initially respond to the chemotherapy treatment (the standard chemotherapeutic drug is gemcitabine), but that they later on begin growing again.  They are attempting to figure out how to bypass the method that cancer cells utilize to defeat chemotherapy treatments.  This approach entails attempts to extrapolate, deduce and figure out how the cancer cell’s metabolism functions.  It is an extremely complex job because scientists only have a very basic, general understanding of how normal cell metabolism works, much less how cancer cell metabolism works.  This may be a major reason why this approach has yielded such meager success.

In order for scientists to figure out a way to kill cancer cells with drugs, they must have a very precise understanding of cell metabolism.  It is very dubious that they will ever find a way to find (or synthesize) chemicals that will have the ability to kill cancer cells without killing normal body cells.

This ‘body as a battlefield’ paradigm has been the dominant conceptual framework for conventional cancer treatment for more than 50 years, and it has been a failure.  Despite the glowing accolades bestowed upon modern cancer treatment, the cure rate is dismal, at best.  It is time for new ideas that seek to establish balance in the body, give the body healthy nutrients, build the body’s own immune system, refrain from butchering the body and cease poisoning it with toxic substances and energies.